newsworker.ru


CRISPR STOCK FORECAST

What is the CRISPR Therapeutics AG stock forecast? · CRISPR Therapeutics AG stock prediction for 1 year from now: $ (%) · CRISPR Therapeutics AG. Analyst Forecast. According to 20 analysts, the average rating for CRSP stock is "Buy." The month stock price forecast is $, which is a decrease of -. CRISPR Therapeutics AG (CRSP) stock forecast and price target · CRSPCRISPR Therapeutics AG. (%). At close: March 1 PM. Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter.

According to analysts' consensus price target of $, CRISPR Therapeutics has a forecasted downside of % from its current price of $ Amount of. CRISPR Therapeutics AG (CRSP) stock price prediction is USD. The CRISPR Therapeutics AG stock forecast is USD for March. Crispr Therapeutics AG Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. CRSP. CRISPR Therapeutics stock prediction on Monday, April, 1: dollars, maximum , minimum CRISPR Therapeutics stock price forecast on Tuesday. The current CRISPR Therapeutics AG [CRSP] share price is $ The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher. Your ultimate guide to investing in healthcare stocks in Learn about the most promising healthcare companies, market forecasts, and investment strategies. Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $ The forecasts range from a low of. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range. CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: USD. The best long-term & short-term CRISPR Therapeutics. CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst. This company's fortunes are likely to improve, and soon. Alex Carchidi. CRISPR Therapeutics is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on.

We maintain our positive long-term outlook and $ fair value estimate. We view the stock as undervalued, trading in 4-star territory about 30% below our fair. CRISPR Therapeutics AG ; Price Momentum. CRSP is trading near the top ; Price change. The price of CRSP shares has decreased $ ; Opened at $ The stock. ; Volume: M · 65 Day Avg: M ; Day Range ; 52 Week Range CRISPR Therapeutics AG ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CRSP will report FY earnings on 02/18/ Yearly Estimates. Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The 18 analysts with month price forecasts for CRSP stock have an average target of , with a low estimate of 30 and a high estimate of The average. Based on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $ with a high estimate of $ and a low. On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $ by Mar 6, The average Crispr Therapeutics Ag stock.

Find the latest Crispr Therapeutics AG (CRSP) stock forecast, month price target, predictions and analyst recommendations. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CRSP will report Your ultimate guide to investing in healthcare stocks in Learn about the most promising healthcare companies, market forecasts, and investment strategies. Mean consensus. OUTPERFORM ; Number of Analysts. 29 ; Last Close Price. USD ; Average target price. 88 USD ; Spread / Average Target. +%. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.

What is CRISPR Therapeutics AG (CRSP)'s stock price history? Over the last year, CRISPR Therapeutics AG's stock price has increased by %. CRISPR. CRISPR Therapeutics AG (newsworker.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock CRISPR Therapeutics AG | Nasdaq. One year price forecast for CRISPR Therapeutics AG has a max estimate of USD and a min estimate of USD. 34 analysts offering month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $ This median of share price forecast. The average one-year price target for CRISPR Therapeutics AG is $ The forecasts range from a low of $ to a high of $ A stock's price.

industrial light and magic stock | no verification withdrawal casino

8 9 10 11 12


Copyright 2013-2024 Privice Policy Contacts SiteMap RSS